The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease

NCT07457125 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Mild to Moderate Alzheimer's Disease

Interventions

DRUG: Exosomes derived from umbilical cord mesenchymal stem cell for intranasal drop
DRUG: A placebo of exosomes derived from umbilical cord mesenchymal stem cell for intranasal drop

Sponsor

Xuanwu Hospital, Beijing

Collaborators

[object Object]
[object Object]